Patents by Inventor Kyosuke Hino

Kyosuke Hino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense Nucleic Acid
    Publication number: 20250084411
    Abstract: The present disclosure relates to an oligonucleotide that expresses functional human WRN protein against skip mutation in the 26th or 28th exon of human WRN gene, or a pharmaceutically acceptable salt thereof, and use thereof.
    Type: Application
    Filed: May 27, 2022
    Publication date: March 13, 2025
    Applicant: SUMITOMO PHARMA CO., LTD.
    Inventors: Zhiqiu MAN, Shigehiro ASANO, Kyosuke HINO
  • Therapeutic agent for fibrodysplasia ossificans progressiva
    Patent number: 11207303
    Abstract: The present invention relates to a prophylactic or therapeutic agent for fibrodysplasia ossificans progressiva comprising as an active ingredient, at least one compound selected from the group consisting of rapamycin, temsirolimus, everolimus, ridaforolimus, TAFA93, umirolimus, olcorolimus, zotarolimus, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: December 28, 2021
    Assignees: Kyoto University, Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Junya Toguchida, Makoto Ikeya, Akira Ohta, Kyosuke Hino
  • Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
    Patent number: 10260068
    Abstract: The invention provides a prophylactic agent or therapeutic agent for fibrodysplasia ossificans progressiva, containing as an active ingredient a binding inhibitor that inhibits interaction between activin and activin A receptor type I (ACVR1), or an expression suppressor that suppresses expression of activin.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: April 16, 2019
    Assignees: Sumitomo Dainippon Pharma Co., Ltd., Kyoto University
    Inventors: Kyosuke Hino, Junya Toguchida, Makoto Ikeya
  • Therapeutic Agent for Fibrodysplasia Ossificans Progressiva
    Publication number: 20180353485
    Abstract: The present invention relates to a prophylactic or therapeutic agent for fibrodysplasia ossificans progressiva comprising as an active ingredient, at least one compound selected from the group consisting of rapamycin, temsirolimus, everolimus, ridaforolimus, TAFA93, umirolimus, olcorolimus, zotarolimus, and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: January 25, 2016
    Publication date: December 13, 2018
    Applicants: Kyoto University, Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Junya Toguchida, Makoto Ikeya, Akira Ohta, Kyosuke Hino
  • Prophylactic Agent and Therapeutic Agent for Fibrodysplasia Ossificans Progressiva
    Publication number: 20170211070
    Abstract: The invention provides a prophylactic agent or therapeutic agent for fibrodysplasia ossificans progressiva, containing as an active ingredient a binding inhibitor that inhibits interaction between activin and activin A receptor type I (ACVR1), or an expression suppressor that suppresses expression of activin.
    Type: Application
    Filed: March 30, 2015
    Publication date: July 27, 2017
    Applicants: Sumitomo Dainippon Pharma Co., Ltd., Kyoto University
    Inventors: Kyosuke Hino, Junya Toguchida, Makoto Ikeya